The Provisional Clinical Opinion The Provisional Clinical Opinion
• "Based on the results of five phase III RCTs, ti t ith d d ll ll l patients with advanced non-small cell lung cancer of the lung who are being considered f fi t li th ith EGFR TKI for first-line therapy with an EGFR TKI (patients who have not previously received h th EGFR TKI) h ld h chemotherapy or an EGFR TKI) should have their tumor tested for EGFR mutations to d t i hi h i i t fi t li determine which is an appropriate first-line therapy: an EGFR TKI or chemotherapy."
INTRODUCTION INTRODUCTION
• The American Society of Clinical Oncology (ASCO) y gy( ) has established a rigorous, evidence-based approach-the provisional clinical opinion (PCO)-ff to offer a rapid response to emerging data in clinical oncology Th PCO i i t d d t ff ti l li i l di ti • The PCO is intended to offer timely clinical direction to ASCO members following publication or presentation of potentially practice-changing data presentation of potentially practice-changing data from major studies 

